FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Verney Sallee

Research Profile

Chemicals & Drugs

Physiology

Intraocular Pressure

Living Beings

Disorders

Procedures

Administration, Topical

Concepts & Ideas

Anatomy

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Mark R Hellberg; Marsha A McLaughlin; Najam A Sharif; Louis DeSantis; Tom R Dean; Evan P Kyba; John E Bishop; Peter G Klimko; Paul W Zinke; Robert D Selliah; George Barnes; Joseph DeFaller; Angela Kothe; Theresa A Landry; E Kenneth Sullivan; Russell Andrew; Alberta A Davis; Lewis Silver; Michael V W Bergamini; Stella Robertson; Alan L Weiner; Verney L Sallee
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Mark R Hellberg; Raymond E Conrow; Najam A Sharif; Marsha A McLaughlin; John E Bishop; Julie Y Crider; W Dennis Dean; Kevin A DeWolf; David R Pierce; Verney L Sallee; Robert D Selliah; Bryon S Severns; Steven J Sproull; Gary W Williams; Paul W Zinke; Peter G Klimko
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
Mark R Hellberg; Verney L Sallee; Marsha A McLaughlin; Najam A Sharif; L Desantis; Tom R Dean; Paul W Zinke
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Verney Sallee (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: Mark R Hellberg; Marsha A McLaughlin; Najam A Sharif; Louis DeSantis; Tom R Dean; Evan P Kyba; John E Bishop; Peter G Klimko; Paul W Zinke; Robert D Selliah; George Barnes; Joseph DeFaller; Angela Kothe; Theresa A Landry; E Kenneth Sullivan; Russell Andrew; Alberta A Davis; Lewis Silver; Michael V W Bergamini; Stella Robertson; Alan L Weiner; Verney L Sallee
Identification and characterization of the ocular hypotensive efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist, and AL-6598, a DP prostaglandin receptor agonist.
Survey of ophthalmology 2002;47 Suppl 1():S13-33.
2002: Mark R Hellberg; Raymond E Conrow; Najam A Sharif; Marsha A McLaughlin; John E Bishop; Julie Y Crider; W Dennis Dean; Kevin A DeWolf; David R Pierce; Verney L Sallee; Robert D Selliah; Bryon S Severns; Steven J Sproull; Gary W Williams; Paul W Zinke; Peter G Klimko
3-Oxa-15-cyclohexyl prostaglandin DP receptor agonists as topical antiglaucoma agents.
Bioorganic & medicinal chemistry 2002;10(6):2031-49.
2001: Mark R Hellberg; Verney L Sallee; Marsha A McLaughlin; Najam A Sharif; L Desantis; Tom R Dean; Paul W Zinke
Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2001;17(5):421-32.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.